SCHEMBL24010753

SCHEMBL24010753

CN(C1=CC=CC1)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9163351 0.72
SCHEMBL5705399 0.70
SCHEMBL517101 0.69
Hydrochloric Acid SCHEMBL4482101 0.69
Hydrochloric Acid SCHEMBL392381 0.69
SCHEMBL24403554 0.69
SCHEMBL28980851 0.67
SCHEMBL12856768 0.65
Dimethylamine SCHEMBL5200560 0.65
SCHEMBL27964409 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021226629-A1 HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS AND METHODS OF USE AMGEN INC. (US) 2021-11-11 WO disclosed